Low incidence of polymorphous light eruption in renal transplant recipients [6]

Acta Dermato-Venereologica

Volumn 87, Issue 4, 2007, Pages 372-374

  Benanni, Bouteina ^a   Bruckner, Thomas ^b   Bock, Michael ^b   Faivre, Brigitte ^a   Rebibou, Jean Michel ^a   Diepgen, Thomas ^b   Humbert, Philippe ^a   Aubin, François ^a  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CANCER RISK; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN PAPILLOMA VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; KIDNEY GRAFT; LETTER; MAJOR CLINICAL STUDY; MALE; PHOTODERMATOSIS; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SKIN CANCER; STATISTICAL SIGNIFICANCE; ULTRAVIOLET RADIATION; VIRUS INFECTION; CASE CONTROL STUDY; FRANCE; KIDNEY TRANSPLANTATION; MIDDLE AGED; PHOTOSENSITIVITY DISORDER; PROSPECTIVE STUDY; SUNLIGHT; TREATMENT REFUSAL;

SUNSCREEN;

ADULT; CASE-CONTROL STUDIES; FEMALE; FRANCE; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHOTOSENSITIVITY DISORDERS; PREVALENCE; PROSPECTIVE STUDIES; QUESTIONNAIRES; SEX FACTORS; SUNLIGHT; SUNSCREENING AGENTS; TREATMENT REFUSAL;

EID: 35348871025     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0248     Document Type: Letter

References (15)

1. Pao C, Norris PG, Corbett M, Hawk JL. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994; 130: 2-4.
2. Palmer RA, Friedmann PS. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J Invest Dermatol 2004; 122: 291-294.
3. van de Pas CB, Kelly DA, Seed PT, Young AR, Hawk JL, Walker SL. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J Invest Dermatol 2004; 122: 295-299.
4. Aubin F. Why is polymorphous light eruption so common in young women? Arch Dermatol Res 2004; 296: 240-241.
5. Norris PG, Morris J, McGibbon DM, Chu AC, Hawk JL. Polymorphic light eruption: an immunopathological study of evolving lesions. Br J Dermatol 1989; 120: 173-183.
6. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
7. Ling TC, Richards HL, Janssens AS, Anastassopoulou L, Antoniou C, Aubin F, et al. Seasonal and latitudinal impact of polymorphic light eruption on quality of life. J Invest Dermatol 2006; 126: 1648-1651
8. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol 2003; 13: 515-523.
9. Kolgen W, Van Weelden H, Den Hengst S, Guikers KL, Kiekens RC, Knol EF, et al. CD11b+ cells and ultraviolet-B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999; 113: 4-10.
10. Schornagel IJ, Sigurdsson V, Nijhuis EH, Bruijnzeel-Koomen CA, Knol EF. Decreased neutrophil skin infiltration after UVB exposure in patients with polymorphous light eruption. J Invest Dermatol 2004; 123: 202-206.
11. Mahe E, Morelon E, Fermanian J, Lechaton S, Pruvost C, Ducasse MF, et al. Renal-transplant recipients and sun protection. Transplantation 2004; 78: 741-744.
12. Donovan JC, Rosen CF, Shaw JC. Evaluation of sun-protective practices of organ transplant recipients. Am J Transplant 2004; 4: 1852-1858.
13. Szepietowski JC, Reich A, Nowicka D, Weglowska J, Szepietowski T. Sun protection in renal transplant recipients: urgent need for education. Dermatology 2005; 211: 93-97.
14. Yoshikawa T, Rae V, Bruins-Slot W, Van den Berg JW, Taylor JR, Streilein JW. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990; 95: 530-536.
15. Fesq H, Ring J, Abeck D. Management of polymorphous light eruption: clinical course, pathogenesis, diagnosis and intervention. Am J Clin Dermatol 2003; 4: 399-406.